Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Tirzepatide reduces HF events in patients with HFpEF and obesity
Tirzepatide reduces HF events in patients with HFpEF and obesity
A Deep Dive into the Pathophysiology of CAH and Its Impact on Treatment
A Deep Dive into the Pathophysiology of CAH and Its Impact on Treatment
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
Navigating Complex CAH Care from Newborn to Adult
Navigating Complex CAH Care from Newborn to Adult
Managing Patients with Congenital Adrenal Hyperplasia
Managing Patients with Congenital Adrenal Hyperplasia
Rethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Rethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
eurekalert.org
ca.news.yahoo.com
healthline.com
medicalxpress.com
newsroom.heart.org
pbrc.edu
